<DOC>
	<DOC>NCT02809794</DOC>
	<brief_summary>The study is to evaluate the product reliability, therapy effectiveness and user feedback of a Continuous Positive Airway Pressure (CPAP) device in-home for up to 6 months.</brief_summary>
	<brief_title>CPAP In-home Assessment Australia</brief_title>
	<detailed_description>Existing and Na√Øve CPAP users will be recruited into a 6 month in-home study Participants will attend 5 study visits at day 0, 7, 30, 60 and 180. Outcome of the clinical investigation include downloadable device data reports, device error reports and participants perception questionnaires.</detailed_description>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<criteria>Aged 18 and over. Diagnosed with OSA by a practicing physician and prescribed Positive Airway Pressure (PAP) therapy. Persons contraindicated for Continuous Positive Airway Pressure (CPAP) therapy. Persons with other significant sleep disorder(s) (e.g. periodic leg movements, insomnia, central sleep apnea). Persons with obesity hypoventilation syndrome or congestive heart failure. Persons that require supplemental oxygen with their CPAP device. Persons with implanted electronic medical devices (e.g. cardiac pacemakers). Persons who are pregnant or think they might be pregnant. Persons whose primary language is other than English. Persons in existing dependent or unequal relationships with any member of the research team, the researcher(s) and/or the person undertaking the recruitment/consent process. Persons highly dependent on medical care. People with cognitive impairment, an intellectual disability or a mental illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>